Medical device manufacturers face strict regulatory requirements when selecting materials for products that come into direct or indirect contact with the human body. Among the most important considerations is biocompatibility, which helps ensure that materials perform safely without causing harmful biological responses. For adhesives used in medical devices, compliance with ISO 10993 is often a critical requirement.

Whether bonding catheters, wearable sensors, diagnostic equipment, or implantable components, understanding ISO 10993 can help engineers select adhesives that support regulatory approval while delivering reliable performance.

What is ISO 10993?

Iso 10993 picture1

ISO 10993 is an internationally recognized series of standards for evaluating the biological safety of medical devices. Rather than certifying individual materials, the standard establishes testing methods that assess how a finished medical device interacts with the human body based on its intended use.

Because adhesives often become an integral part of a finished medical device, manufacturers frequently seek adhesive products that have been tested to relevant portions of ISO 10993. This testing provides valuable information during the device validation process and can reduce the amount of additional biological testing required.

The specific tests required depend on several factors, including:

  • Type of body contact
  • Duration of contact
  • Whether the device contacts skin, tissue, blood, or bone
  • Whether the device is temporary or permanently implanted

 

Common ISO 10993 Tests for Adhesives

Not every adhesive requires every test within the ISO 10993 series. The most commonly referenced evaluations for medical adhesives include:

Cytotoxicity (ISO 10993-5)

Cytotoxicity testing evaluates whether an adhesive causes toxic effects on cultured cells. This is often considered the first biological screening test for materials intended for medical use.

Citotoxycity test

Sensitization (ISO 10993-10)

Sensitization testing determines whether repeated exposure to the adhesive could trigger an allergic reaction in patients.

Irritation Testing (ISO 10993-23)

This testing evaluates whether the adhesive causes localized irritation when it comes into contact with skin or other tissues.

Systemic Toxicity

Depending on the intended application, testing may evaluate whether chemicals released from the adhesive could produce harmful effects throughout the body.

Additional Testing

Implantable devices or long-term contact applications may require further evaluations such as:

  • Genotoxicity
  • Hemocompatibility
  • Implantation studies
  • Chemical characterization
  • Material-mediated pyrogenicity

The testing strategy is determined through a biological risk assessment based on the device’s intended clinical use.

 

Leave a Reply